本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Immunovant, Inc.

15.07
+0.62004.29%
盘前15.800.7300+4.84%04:17 EDT
成交量:90.25万
成交额:1,345.68万
市值:25.60亿
市盈率:-5.76
高:15.11
开:14.45
低:14.41
收:14.45
数据加载中...
2020/08/25

重要事件披露

8-K - Current report
2020/08/21

重要事件披露

8-K - Current report
2020/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/12

重要事件披露

8-K - Current report
2020/06/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/06/29

重要事件披露

8-K - Current report
2020/06/15

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/05/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/14

重要事件披露

8-K - Current report
2020/04/17

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/10

招股说明书

General form for registration of securities under the Securities Act of 1933
2020/04/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/04/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/08

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2020/04/03

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/03/30

重要事件披露

8-K - Current report
2020/02/28

SEC问询函

CORRESP [Cover] - Correspondence